Whereas bacterial artificial chromosomes (BAcs) offer many advantages in studies of gene and protein function, generation of seamless, precisely mutated BAcs has been difficult. here we describe a counterselection-based recombineering method and its accompanying reagents. After identifying intramolecular recombination as the major problem in counterselection, we built a strategy to reduce these unwanted events by expressing redb alone at the crucial step. We enhanced this method by using phosphothioated oligonucleotides, using a sequencealtered rpsL counterselection gene and developing online software for oligonucleotide design. We illustrated this method by generating transgenic mammalian cell lines carrying small interfering rnA-resistant and point-mutated BAc transgenes. using this approach, we generated mutated TACC3 transgenes to identify phosphorylation-specific spindle defects after knockdown of endogenous TACC3 expression. our results highlight the complementary use of precisely mutated BAc transgenes and rnA interference in the study of cell biology at physiological expression levels and regulation.
Whereas bacterial artificial chromosomes (BAcs) offer many advantages in studies of gene and protein function, generation of seamless, precisely mutated BAcs has been difficult. here we describe a counterselection-based recombineering method and its accompanying reagents. After identifying intramolecular recombination as the major problem in counterselection, we built a strategy to reduce these unwanted events by expressing redb alone at the crucial step. We enhanced this method by using phosphothioated oligonucleotides, using a sequencealtered rpsL counterselection gene and developing online software for oligonucleotide design. We illustrated this method by generating transgenic mammalian cell lines carrying small interfering rnA-resistant and point-mutated BAc transgenes. using this approach, we generated mutated TACC3 transgenes to identify phosphorylation-specific spindle defects after knockdown of endogenous TACC3 expression. our results highlight the complementary use of precisely mutated BAc transgenes and rnA interference in the study of cell biology at physiological expression levels and regulation.
BAC transgenes usually deliver the physiological expression of the genes they carry because they are large enough to retain all cis-regulatory elements in the native configuration in addition to alternative splice isoforms, translational and miRNA controls and alternate polyadenylation sites. Consequently, BACs are a more accurate way of probing protein function than traditional studies based on complementary DNA, which often use viral promoters that have problems with deregulation and overexpression. To achieve fluent BAC transgenesis, efficient recombineering methods have been developed for BAC modifications such as protein tagging. However, seamless site-directed mutagenesis in BACs remains problematic. Here we address these problems.
Recombineering is the use of homologous recombination to engineer DNA molecules, primarily in Escherichia coli [1] [2] [3] . The inherent flexibility of recombineering permits a wide variety of DNA manipulations, including techniques for protein tagging or subcloning to make targeting constructs [4] [5] [6] , and several applications of this method have been adapted to genome-scale highthroughput pipelines [7] [8] [9] .
The advantages of BAC transgenesis can also be applied to detailed structure-function analyses using site-directed mutagenesis. A number of examples have already been published, including our recent work to examine protein function in cultured cells in an RNA interference (RNAi)-resistant background 10, 11 . There are relatively few examples of the successful application of this technique because using current methods, site-directed BAC mutagenesis remains difficult and unpredictable, and each mutational exercise usually requires a period of intense individual attention. Here we tackle the challenge of simplifying site-directed mutagenesis by recombineering.
Ideally, site-directed mutations should be seamless so that the final product does not include any unnecessary sequence that was acquired during mutagenesis. This is particularly important for mutagenesis in protein-coding regions, where extraneous DNA sequences will be mutagenic. Seamless BAC mutagenesis can be achieved using two sequential reactions [12] [13] [14] . First, a dual selection-counterselection cassette is inserted by selection for antibiotic resistance. Second, loss of this cassette and its replacement by exogenous sequences is counterselected as a result of the toxicity produced by the counterselectable gene under specific conditions (here we used sensitivity to streptomycin conferred by the wild-type rpsL gene [14] [15] [16] ; Fig. 1a,b) . Despite the usefulness of these recombineering strategies, the efficiency of correct recombinant recovery after the counterselection step varies widely, and sometimes this recovery fails completely. Incorrect recombinants seem to most often result from unwanted intramolecular recombination 17, 18 (Supplementary Fig. 1 ).
Recombineering usually uses the proteins of the λ phage Red operon, termed Redγ, Redβ and Redα. Redγ is an inhibitor of the RecBCD exonuclease 19, 20 , Redβ is a single-stranded annealing protein 21 and Redα is a 5′ to 3′ exonuclease 22, 23 . Recent evidence indicates that Red recombination proceeds at the replication fork through a Redα-generated single-stranded intermediate 24, 25 . In this mechanism, Redβ mediates the incorporation of a fulllength single-stranded molecule carrying 5′ and 3′ homology regions into the replication fork 14, 26 . The Red proteins can also mediate alternate recombination mechanisms such as synthesisdependent strand annealing 27 . In this mechanism, intramolecular recombination is initiated by a double-strand break that is resected by Redα, resulting in two single-stranded regions. If these regions contain a sequence repeat, annealing at the repeat can lead to recombination with loss of sequences around the double-strand break (Fig. 1c) .
With these considerations in mind, we developed a more efficient and predictable strategy for counterselection. By modifying the application of the Red proteins to reduce synthesis-dependent strand annealing and optimizing oligonucleotide design, we markedly increased the efficiency of seamless mutagenesis. We present here a detailed protocol for generating mutations in BAC constructs using these methods, including the generation of cell lines for controlled genetic analysis and an online oligonucleotide design tool for constructing mutations. results intramolecular recombination impedes counterselection A general scheme for introducing point mutations into a gene of interest using an rpsL-neo cassette and oligonucleotide rescue by counterselection is presented in Figure 1 . The first step is a standard recombineering step to select for the integration of the rpsL-neo cassette (Fig. 1a) . After induction of the Redγβα proteins, electroporation of the PCR product and selection on kanamycin results in the introduction of the cassette at the chosen target site. In the second step (Fig. 1b) , an oligonucleotide that is at least 100 nt long and that contains the planned point mutation(s) located at the center is electroporated after the induction of Redγβα proteins, which is followed by selection on streptomycin (for loss of the cassette) and chloramphenicol (to maintain the BAC). The correct event results in the replacement of the rpsL-neo cassette with the oligonucleotide. The competing, incorrect events are expected to involve intramolecular recombination and result in deletion of the rpsL-neo cassette and the surrounding DNA (Fig. 1c) .
To test this process, we aimed to introduce point mutations into two mammalian BACs containing the genes TPX2 and TACC3. After integrating the counterselection cassettes in the first step, we measured the frequency of streptomycin-resistant cells after counterselection with or without the corresponding TPX3 or TACC3 mutagenizing oligonucleotides (Fig. 1d) . The presence of the oligonucleotides had no observable effect on the number of streptomycin-resistant colonies, indicating that most of these colonies arose from unwanted recombination events. Accordingly, the frequency of the correct integration event, as measured by PCR analysis, was low (4% and 7% for TPX2 and TACC3, respectively; Fig. 1e ). Incorrect events almost always resulted in no PCR product, suggesting that large DNA sequences had been deleted. Examination of the BAC minipreps supported the conclusion that most of the streptomycin-resistant colonies arose from intramolecular recombination that deleted the rpsL gene (the gene that conveys sensitivity to streptomycin) ( Supplementary Fig. 1 ).
A resistance gene at the target site eliminates deletions
We reasoned that the inclusion of a second selectable gene near the counterselection cassette would permit selection against most of the unwanted intramolecular recombination events. Therefore, we introduced the bla gene, which conveys ampicillin resistance, 300 bp from the counterselection cassette in the TPX2 BAC using a second standard recombineering step (Fig. 1f ) . We then applied both streptomycin and ampicillin so that unwanted deletions (as in Fig. 1c ) would be selected against. In contrast to the previous TPX2 experiments, under these conditions we found no colonies after electroporating without the oligonucleotide (Fig. 1d) , and all of the colonies that we obtained using the oligonucleotide contained the correct event (Fig. 1e) . (e) Efficiency of the integration of the oligonucleotide and replacement of the counterselection cassette. Shown is the percentage of antibiotic-resistant colonies that contained the desired recombination event (4%, 7% and 100% for TPX2, TACC3 and TPX2 plus ampicillin selection, respectively). (f) The ampicillin resistance gene bla was inserted 300 nt downstream of the mutation site, within an intron, to select against intramolecular recombination. Kan, kanamycin; str, streptomycin; chl, chloramphenicol; amp, ampicillin; + oligo, 40 pmol oligonucleotide; no oligo, no added oligonucleotide.
Unwanted recombination events are therefore eliminated by inserting a selectable marker near the site of interest, strongly arguing that these unwanted events are caused by intramolecular recombination. To minimize the impact of introducing the second selectable marker on gene function, we inserted the marker in an intron and flanked it with site-specific recombination target sites (loxP) for removal by Cre recombinase using standard techniques 1, 28 . Although this strategy solves the problem of intramolecular recombination, the extra steps add work, time and cost to the procedure, and the resulting product is not seamlessly mutated.
circumventing intramolecular recombination
Red-mediated oligonucleotide mutagenesis uses a different recombination mechanism than intramolecular recombination via an annealing intermediate. The latter is stimulated by Redα exonuclease resection of a double-strand break, whereas the former does not require Redα 14, 26 . We reasoned that by omitting Redα during counterselection, the unwanted intramolecular recombination events in the second counterselection step could be circumvented and oligonucleotide mutagenesis would be unaffected.
To test this prediction, we repeated the experiments for oligonucleotide-based counterselection, as in Figure 1 , and tested different combinations of Red proteins: γβα, γβ, β, βα and no protein (Fig. 2a,b) . We used oligonucleotides complementary to the leading or lagging strands at the site of mutagenesis in addition to a heterologous sequence and a control containing no oligonucleotide. This experiment revealed two useful insights. First, the oligonucleotide that can prime Okazaki fragment synthesis at the replication fork (termed here 'lagging') delivered more correct recombinants than its complementary oligonucleotide ('leading'), as we expected 14, 26 . Second, expression of Redβ alone resulted in fewer recombinants than the other combinations of Red proteins; however, the percentage of correct events was the highest with expression of Redβ alone, suggesting that unwanted double-stranded DNA (dsDNA) intramolecular recombination events were selectively diminished in this context (Fig. 2b) . Notably, co-expression of Redβ and Redγ resulted in more (mostly incorrect) recombinants than expression of Redβ alone. This suggests that Redα is dispensable in standard dsDNA recombineering applications such as cassette integration, which we used here as the first step in the recombineering process. To test this, we used a recombination efficiency assay 29 with a linear dsDNA substrate and different combinations of Red proteins (Fig. 2c) . Consistent with the findings described above, recombination was only slightly reduced when using Redγβ as compared to Redγβα.
We therefore constructed a new strategy for site-directed mutagenesis in which the first step is mediated by Redβ and Redγ and the second step is mediated by Redβ alone (Fig. 2d) . We constructed a new expression plasmid, pABRG (Fig. 3a) , so that expression of Redβ alone could be induced by l-arabinose and dual expression of Redβ and Redγ could be induced by administration of l-arabinose and l-rhamnose.
Because 5′ phosphothioates improve the efficiency of recombineering using dsDNA 24 , we examined the effect of adding 5′ phosphothioate bonds to oligonucleotides in a single-strand oligonucleotide repair assay that was mediated by Redβ alone (Fig. 3b) . As with dsDNA and Redγβα, inclusion of two phosphothioate bonds delivered the maximum benefit.
We used the pABRG and phosphothioated oligonucleotide strategy for counterselection-based mutagenesis, as in Figure 1 , the frequency of recombinants resistant to both streptomycin and chloramphenicol recovered as a percentage of all surviving cells was evaluated after induction with different Red protein combinations (Redγβα, Redγβ, Redβ, Redβα or no Red protein expression (−)) and transfection of different 100-nt oligonucleotides (no oligo, no oligonucleotide was included in the electroporation; hetero, heterologous sequence; leading, complementary to the leading strand template; lagging, complementary to the lagging strand template). Error bars, s.d. n = 3. (b) The same process was used as in a, except here, the efficiency of the integration of the oligonucleotide and replacement of the counterselection cassette is plotted. (c) Recombination efficiency assay with a linear dsDNA substrate and different combinations of Red proteins. dsDNA was PCR amplified to contain the blasticidin resistance gene with 2× phosphothioates on either the 5′ end of the strand that can prime Okazaki fragment synthesis (dsLG) or the opposite strand (dsLD). Blasticidin-resistant recombinants were scored and normalized to transformation efficiency. (d) The new counterselection strategy using differential expression of Red proteins in the first and second steps. Introduction of an rpsL-neo counterselection cassette is mediated by co-induction of Redγ and Redβ with l-rhamnose and l-arabinose and selection on kanamycin. Replacement of the counterselection cassette by an oligonucleotide containing homologous ends and a mutation of interest is mediated by arabinose induction of Redβ alone and selection on streptomycin and chloramphenicol. Intramolecular recombination is largely avoided in this approach (right). Str, streptomycin; chl, chloramphenicol.
but with an rpsL-bla instead of an rpsL-neo cassette. First, the cassette was integrated by expression of both Redβ and Redγ. Then, we induced Redβ alone for the counterselection step and used three different oligonucleotides: leading, lagging and lagging with two 5′ phosphothioate bonds (Fig. 3c,d) . The lagging oligonucleotide delivered a higher percentage of correct recombinants than the leading oligonucleotide (39% compared to 21%, respectively), as we expected. We further improved this percentage to 80% using 5′ phosphothioates. Sequencing of individual recombinant BACs across the mutation site confirmed the correct integration of the mutation in six out of six isolates (data not shown). We obtained similar efficiencies using 22 different mutations in ten genes (Fig. 3e) .
new counterselection cassettes based on Photorhabdus rpsL
In the course of working with rpsL counterselection, we occasionally observed unwanted homologous recombination between the wild-type rpsL gene in the counterselection cassette and the endogenous streptomycin-resistant rpsL gene, which generated streptomycin-sensitive host cells that were defective for counterselection. We reasoned that this recombination could be lessened by using an rpsL gene with reduced sequence homology to the E. coli rpsL gene. Therefore, we cloned the rpsL gene from Photorhabdus luminescens, verified that it could be used for counterselection in E.coli and then optimized it to ensure that (i) the E. coli rpsL amino acid sequence was retained and (ii) there was no region of continuous identity with the E. coli gene longer than 13 bp (Supplementary Fig. 2) . To expand the counterselection toolbox, we combined the optimized P. luminescens rpsL gene with several selectable genes (neo (kanamycin resistance), bla (ampicillin resistance), gen (gentamycin resistance), bsd (blasticidin resistance) and tetA (tetracycline resistance)) in an R6K plasmid context to eliminate carryover background during recombineering 15 (Fig. 3f) .
BAcfinder 2.0: an online oligonucleotide design tool
Correct oligonucleotide design is crucial in recombineering, so we developed an online counterselection design tool for any given mutation (for example, a base change, a deletion or an insertion, among many others) called BACfinder2.0 (http://www.mitocheck. org/cgi-bin/BACfinder2). The program generates (i) primer pairs for PCR amplification of the counterselection cassette to attach the homology arms; (ii) the oligonucleotide containing the desired mutation(s) for the counterselection step; and (iii) primer pairs for colony PCR to check cassette integration and replacement. Notably, this tool determines which strand to order for the lagging oligonucleotide. After the user inputs a gene name and a desired mutation, BACfinder2.0 outputs the BAC to order, as well as all the Fig. 3 for screenshots and Supplementary Protocol 1 for details on using the program).
Generation of multiple targeted mutations
To validate the new method, we generated nine RNAi-resistant mutations in mitotic and checkpoint genes in human and mouse BACs ( Table 1) . These BAC transgenes had already been tagged on the C terminus with fluorescent proteins 6, 8 . We altered previously verified small interfering RNA (siRNA) target sequences by changing the nucleotides at amino acid wobble positions and achieved a consistently high efficiency of correct recombinants (89% on average; Table 1 ). We modified these BACs in parallel in one recombineering exercise. We then used the siRNA-resistant TACC3 and GTSE1 BAC constructs to generate site-directed mutations for use in functional studies using a second recombineering exercise ( Table 1 and Fig. 4a,b) . After obtaining the oligonucleotides, the two consecutive recombineering steps (siRNA resistance and site-directed mutations) and the sequence confirmation of the products took a total of 2 weeks.
Analysis of TACC3 mutations in rnAi-resistant transgenes
We used TACC3 BACs mutated at their phosphorylation sites (Fig. 4a,b) to study the role of TACC3 phosphorylation in human cells. TACC3 is a protein that localizes to the mitotic spindle and has established roles in mitosis and microtubule dynamics (reviewed in ref. 30) . TACC3 is known to be phosphorylated by the mitotic kinase Aurora A at specific serine residues 31, 32 . Recent evidence has shown that phosphorylation of TACC3 mediates its recruitment to spindles through a phosphodependent interaction with clathrin heavy chain 11, 33, 34 .
We compared the effect of abolishing this interaction using alteration of TACC3 phosphorylation sites and RNAi-mediated depletion of TACC3 protein by transfecting RNA-resistant wild-type a AURKA is also known as AURA and encodes Aurora A, and AURKB is also known as AURB and encodes Aurora B. b Average for all the above mutations. (TACC3 WT ) and mutagenized (TACC3 AAA ) BACs into cells from the osteosarcoma cell line U2OS. We selected stable integrants (Supplementary Protocol 1) and analyzed individual clones using a western blot with antibodies to TACC3 and imaging of GFP expression. We identified clones that expressed the TACC3 transgene at endogenous levels. Western blot analysis after RNAi confirmed that the transgenic TACC3 was RNAi-resistant (Fig. 4c) . We then analyzed the clones for defects in mitotic spindle assembly using immunoflourescence. As TACC3 depletion itself has relatively subtle mitotic spindle phenotypes, performing this experiment accurately required the physiological expression level provided by a BAC construct as well as the ability to selectively deplete the endogenous protein.
Depletion of TACC3 resulted in mitotic cells with a 'wavy' spindle phenotype, in which half spindles often have a concave rather than a wild-type convex morphology and the astral microtubules were not detectable (Fig. 4d,e) . Expression of the RNAiresistant TACC3 transgene rescued this spindle defect (Fig. 4e) . In contrast to TACC3 depletion, expression of TACC3 AAA did not result in an increase in the wavy spindle phenotype but, rather, led to an increase in small, collapsed spindles (Fig. 4d,f) . Thus, the phosphorylation-resistant TACC3 mutant, although unable to localize to the mitotic spindle, showed a spindle assembly defect distinct from that resulting from TACC3 depletion. Notably, the collapsed spindle phenotype is very similar to the appearance of the spindles resulting from partial inhibition of Aurora A activity by alteration of the activator TPX2 (ref. 10). These results suggest that the effects of TACC3 on spindle morphology are not only related to its recruitment through clathrin to the spindle, as depletion of TACC3 has a different phenotype than the mutant. Furthermore, these results serve as an illustration of the precision that can be achieved with the improved counterselection strategy, which permitted the construction of a complex, multiply mutated BAC transgene for functional studies.
discussion
The advent of recombineering has facilitated a variety of functional genomic and proteomic applications, including genomescale protein-tagging and gene-knockout projects 9 . However, difficulties with counterselection strategies have limited the routine application of site-directed mutagenesis by recombineering. We outlined methods and resources that greatly increase the efficiency and ease of precise, seamless BAC mutagenesis. For convenient application, we built a new plasmid using Redβ under arabinose induction and one using Redγ under rhamnose induction.
By expressing Redβ alone during the crucial counterselection step and by optimizing oligonucleotide design, we enhanced seamless site-directed mutagenesis by an order of magnitude compared to previous counterselection strategies, yielding, on average, 89% correct recombinants in the final step. With this efficiency, recombineering pipelines 7 for site-directed mutagenesis are now feasible. Large-scale counterselection recombineering will allow for the rapid generation of single mutations within many different genes (for example, RNAi resistance for RNAi target verification) or many combinatorial mutations within a single gene (for example, phosphorylation site mutations for structure-function analyses). methods Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website.
